Indeed, using lung cancer cell, xenograft and clinical models, we revealed a novel role of ZNF322A in lung CSC-like reprogramming maintenance and cell motility promotion through suppressing c-Myc expression at the transcriptional level causing a metabolic shift toward oxidative phosphorylation in lung cancer stem-like cells. The gene discussed is ZNF322; the disease is lung cancer.